## Abstract The nonmotor symptoms (NMS) of Parkinson's disease (PD) are less well recognised and can be more troublesome to patients and carers than classical motor features. NMS are frequently missed during routine consultations and such underβrecognition may have implications on quality of care g
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
β Scribed by Pablo Martinez-Martin; Anthony H.V. Schapira; Fabrizio Stocchi; Kapil Sethi; Per Odin; Graeme MacPhee; Richard G. Brown; Yogini Naidu; Lisa Clayton; Kazuo Abe; Yoshio Tsuboi; Dough MacMahon; Paolo Barone; Martin Rabey; Ubaldo Bonuccelli; Alison Forbes; Kieran Breen; Susanne Tluk; C. Warren Olanow; Sue Thomas; David Rye; Annette Hand; Adrian J. Williams; William Ondo; K. Ray Chaudhuri
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 204 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
2006, there was, no single instrument (questionnaire or scale) for attempting a comprehensive assessment of the wide range of nonmotor symptoms (NMS) of Parkinson's disease (PD). The PD nonmotor group, a multidisciplinary group of experts including patient group representatives developed and validated the NMS screening questionnaire (NMSQuest) comprising 30 items. The NMSQuest is a self completed screening tool designed to draw attention to the presence of NMS. In this paper, we present the results gathered from 545 patients using the definitive version of the NMSQuest highlighting the prevalence of the wide range of NMS flagged in the NMSQuest from consecutive PD patients in an international setting. Β© 2007 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract We performed a crossβsectional study of 82 Chinese patients with Parkinson's disease (PD) enrolled during an 18βmonth period using a clinical interview to assess the prevalence of nonmotor symptoms (NMS), the association with disease severity and motor status, and the impact on patients
## Abstract Switching from oral medications to continuous infusion of levodopa/carbidopa gel reduces motor complications in advanced Parkinson's disease (PD), but effects on nonmotor symptoms (NMSs) are unknown. In this prospective openβlabel observational study, we report the effects of intrajejun